Singapore markets closed

Lyell Immunopharma, Inc. (LYEL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.2300+0.1900 (+9.31%)
At close: 04:00PM EDT
2.2493 +0.02 (+0.87%)
After hours: 07:24PM EDT
Show:
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
145,647
123,554
293,828
140,406
Other short-term investments
400,576
516,598
320,966
472,213
Total cash
546,223
640,152
614,794
612,619
Other current assets
8,463
11,143
11,492
4,928
Total current assets
554,686
651,295
626,286
617,547
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
193,964
198,649
181,152
129,159
Accumulated depreciation
-51,647
-32,384
-14,513
-5,104
Net property, plant and equipment
142,317
166,265
166,639
124,055
Equity and other investments
48,507
115,041
330,532
163,443
Other long-term assets
4,519
4,960
3,949
3,235
Total non-current assets
195,343
286,266
501,120
290,733
Total assets
750,029
937,561
1,127,406
908,280
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
4,817
3,917
3,207
9,396
Accrued liabilities
5,726
6,422
9,123
8,897
Deferred revenues
-
0
4,988
6,095
Other current liabilities
3,069
6,708
10,955
6,430
Total current liabilities
34,519
37,028
46,738
49,285
Non-current liabilities
Deferred revenues
-
0
79,665
89,066
Other long-term liabilities
3,664
4,113
4,566
532
Total non-current liabilities
60,558
67,281
150,881
140,555
Total liabilities
95,077
104,309
197,619
189,840
Stockholders' equity
Common stock
25
25
24
1,010,970
Retained earnings
-1,002,112
-767,480
-584,362
-334,143
Accumulated other comprehensive income
-94
-7,599
-1,623
256
Total stockholders' equity
654,952
833,252
929,787
718,440
Total liabilities and stockholders' equity
750,029
937,561
1,127,406
908,280